Enablex and Night sweats - a phase IV clinical study of FDA data

Summary:

Night sweats is reported as a side effect among people who take Enablex (darifenacin hydrobromide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Restasis, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Night sweats when taking Enablex. It is created by eHealthMe based on reports of 4,746 people who have side effects when taking Enablex from the FDA, and is updated regularly.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.

What is Night sweats?

Night sweats (sweating in night) is found to be associated with 1,527 drugs and 1,689 conditions by eHealthMe. Check the latest studies of Night sweats.

On Jul, 26, 2026

4,746 people reported to have side effects when taking Enablex.
Among them, 16 people (0.34%) have Night sweats.

Among these 16 people:

How long have people been on Enablex when they have Night sweats? *

What is the gender of people who have Night sweats when taking Enablex? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Night sweats when taking Enablex? *

What are other drugs people take besides Enablex? *

What are other side effects people have besides Night sweats? *

Back Pain: 10 people, 62.50%
Fatigue (feeling of tiredness): 10 people, 62.50%
Abdominal Pain Upper: 8 people, 50.00%
Drug Ineffective: 8 people, 50.00%
Joint Pain: 8 people, 50.00%
Insomnia (sleeplessness): 8 people, 50.00%
Sinusitis (inflammation of sinus): 8 people, 50.00%
Headache (pain in head): 8 people, 50.00%
Stomatitis (inflammation of mucous membrane of mouth): 8 people, 50.00%
Ear Pain: 8 people, 50.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 50.00%
Joint Pain: 5 people, 31.25%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 18.75%
Cystitis Ulcerative (inflammation of the wall of the bladder with ulcer): 2 people, 12.50%
Pain: 2 people, 12.50%
Urinary Tract Infection: 2 people, 12.50%
Gastric Ulcer (stomach ulcer): 2 people, 12.50%
Hiv Infection: 2 people, 12.50%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Enablex and have Night sweats?

- Check whether Night sweats is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enablex:

Enablex (4,934 reports)

Night sweats treatments and more:

Night sweats (40,332 reports)

Browse all side effects of Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Night sweats:

Night sweats (1,527 drugs)

Browse all the conditions that are associated with Night sweats:

Night sweats (1,689 conditions)

Related publications that referenced our studies

Murday HK, Rusli FD, Blandy C, Vollenhoven B, "Night sweats: it may be hemochromatosis", Climacteric, 2016 Jul .
Murday HK, Rusli FD, Blandy C, Vollenhoven B, "Night sweats: it may be hemochromatosis", Climacteric, 2016 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on darifenacin hydrobromide (the active ingredients of Enablex) and Enablex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.